Sign up
Pharma Capital
EPIC: THC
Market: ASX
52-week High/Low: A$1.15 / A$0.19
Sector: Pharma & Biotech
Market Cap: A$48.71M
Website: www.thcl.com.au

The Hydroponics Company Ltd (ASX:THC) operates under a pharmaceutical model and is currently delivering high quality medicinal cannabis products to Australian patients through the existing access schemes.

Hydroponics Company Ltd

www.thcl.com.au

Interactive graph

col 3
col 4
col 5
col 6

Big picture - Why invest in Hydroponics Company Ltd

Hydroponics Company Ltd Snapshot

THC is at the forefront of developing a leading, diversified worldwide cannabis business, focusing on two core business units: Development and delivery of medicinal cannabis, and manufacturing and distribution of hydroponics equipment, materials and nutrients.

IP RESEARCH & DEVELOPMENT



(click here for more information on this project)

 


Last updated 16th July 2018

 

 

 

 

 

 

Suite 305, 35 Lime Street, Sydney, NSW, 2000, Australia

+61 2 9251 7177

[email protected]

View full THC profile View Profile
View All

Executive video interviews

VIEW ALL VIDEOS

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.